Skip to main content
Top
Published in: Pediatric Nephrology 2/2006

01-02-2006 | Original Article

Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure

Authors: Aydın Ece, Yıldız Atamer, Fuat Gürkan, Mehmet Davutoğlu, Meki Bilici, Murat Tutanç, Ali Güneş

Published in: Pediatric Nephrology | Issue 2/2006

Login to get access

Abstract

Increased oxidative stress is believed to contribute to an increased risk of cardiovascular disease in uraemia. In children with chronic renal failure (CRF), an anti-oxidant enzyme, paraoxonase (PON), that inhibits oxidation of LDL-cholesterol, has not been previously investigated. In this study we aimed to investigate PON activity, total anti-oxidant response (TAR), total peroxide (TPX), oxidative stress index (OSI) and some pro-oxidant cytokines in 29 children with CRF [mean age 10.2±3.5 years; 19 pre-dialysis, ten on continuous ambulatory peritoneal dialysis (CAPD)] and in 25 control subjects. Children with CRF had lower PON and TAR and higher TPX and OSI values than did controls (P<0.05). Except for lower TAR and serum albumin levels of the CAPD subgroup (P<0.05), other parameters were similar in non-dialysis and CAPD patients (P>0.05). Patients had significant positive correlation between TAR and serum albumin (P<0.05). Serum urea had significant positive correlation with TPX and OSI (P<0.05). Increased oxidative stress and decreased anti-oxidants measured by serum PON activity and TAR were found in children with CRF. We can hypothesize, on the basis of statistical correlations, that low levels of serum albumin and high levels of uraemic metabolites might be responsible for increased oxidative stress in children with CRF. Further studies with larger sample sizes are needed to verify these results.
Literature
1.
go back to reference Baigent C, Burbury K, Wheeler D (2000) Premature cardiovascular disease in chronic renal failure. Lancet 356:147–152CrossRefPubMed Baigent C, Burbury K, Wheeler D (2000) Premature cardiovascular disease in chronic renal failure. Lancet 356:147–152CrossRefPubMed
2.
go back to reference Foley R, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 [Suppl]:S112–S119 Foley R, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 [Suppl]:S112–S119
3.
go back to reference Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C (2003) Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 18:1272–1280CrossRefPubMed Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C (2003) Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 18:1272–1280CrossRefPubMed
4.
go back to reference Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T (2001) Endothelial dysfunction, oxidative stress and risk of cardiovascular events in patients with coronary artery disease. Circulation 104:2673–2678PubMed Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T (2001) Endothelial dysfunction, oxidative stress and risk of cardiovascular events in patients with coronary artery disease. Circulation 104:2673–2678PubMed
5.
go back to reference Diepeveen SHA, Verhoeven GH, van der Palen J, Dikkeschei B, van Tits LJ, Kolsters G, Offerman J, Bilo HJG, Stalenhoef AFH (2004) Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy. Nephron Clin Pract 98:c3–c7CrossRefPubMed Diepeveen SHA, Verhoeven GH, van der Palen J, Dikkeschei B, van Tits LJ, Kolsters G, Offerman J, Bilo HJG, Stalenhoef AFH (2004) Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy. Nephron Clin Pract 98:c3–c7CrossRefPubMed
6.
go back to reference Annuk M, Fellstrom B, Akerblom O, Zilmer K, Vihalemm T, Zilmer M (2001) Oxidative stress markers in pre-uremic patients. Clin Nephrol 56:308–314PubMed Annuk M, Fellstrom B, Akerblom O, Zilmer K, Vihalemm T, Zilmer M (2001) Oxidative stress markers in pre-uremic patients. Clin Nephrol 56:308–314PubMed
7.
go back to reference Nguyen-Khoa T, Massy ZA, DeBandt JP, Kebede M, Salama L, Lambrey G, Witko-Sarsat V, Drueke TB, Lacour B, Thevenin M (2001) Oxidative stress and hemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 16:335–340CrossRefPubMed Nguyen-Khoa T, Massy ZA, DeBandt JP, Kebede M, Salama L, Lambrey G, Witko-Sarsat V, Drueke TB, Lacour B, Thevenin M (2001) Oxidative stress and hemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 16:335–340CrossRefPubMed
8.
go back to reference Mackness MI, Mackness B, Durrington PN, Connely PW, Hegele RA (1996) Paraoxonase: biochemistry, genetics and relationship to plasma proteins. Curr Opin Lipidol 7:69–76PubMed Mackness MI, Mackness B, Durrington PN, Connely PW, Hegele RA (1996) Paraoxonase: biochemistry, genetics and relationship to plasma proteins. Curr Opin Lipidol 7:69–76PubMed
9.
go back to reference Dirican M, Akca R, Sarandol E, Dilek K (2004) Serum paraoxonase activity in uremic predialysis and hemodialysis patients. J Nephrol 17:813–818PubMed Dirican M, Akca R, Sarandol E, Dilek K (2004) Serum paraoxonase activity in uremic predialysis and hemodialysis patients. J Nephrol 17:813–818PubMed
10.
go back to reference Sutherland WH, de Jong SA, Walker RJ (2004) Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study. Nephrol Dial Transplant 19:75–82CrossRefPubMed Sutherland WH, de Jong SA, Walker RJ (2004) Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study. Nephrol Dial Transplant 19:75–82CrossRefPubMed
11.
go back to reference Dantoine TF, Debord J, Charmes JP, Merle L, Marquet P, Lachatre G, Leroux-RC (1998) Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 9:2082–2088PubMed Dantoine TF, Debord J, Charmes JP, Merle L, Marquet P, Lachatre G, Leroux-RC (1998) Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 9:2082–2088PubMed
12.
go back to reference Massy ZA, Nguyen-Khoa T (2002) Oxidative stress and chronic renal failure: markers and management. J Nephrol 15:336–341PubMed Massy ZA, Nguyen-Khoa T (2002) Oxidative stress and chronic renal failure: markers and management. J Nephrol 15:336–341PubMed
13.
go back to reference Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119CrossRefPubMed Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119CrossRefPubMed
14.
go back to reference Harma M, Harma M, Erel O (2003) Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 133:563–566PubMed Harma M, Harma M, Erel O (2003) Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 133:563–566PubMed
15.
go back to reference Yanik M, Erel O, Kati M (2004) The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatr 16:200–203CrossRef Yanik M, Erel O, Kati M (2004) The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatr 16:200–203CrossRef
16.
go back to reference Harma M, Harma M, Erel O (2005) Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol 10; 118:47–51 Harma M, Harma M, Erel O (2005) Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol 10; 118:47–51
17.
go back to reference Furlong CE, Richter RJ, Seidel SL, Costa LG, Matulsky AG (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180:242–247CrossRefPubMed Furlong CE, Richter RJ, Seidel SL, Costa LG, Matulsky AG (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180:242–247CrossRefPubMed
18.
go back to reference Miyazawa T (1989) Determination of phospholipids hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Med 7:209–217CrossRefPubMed Miyazawa T (1989) Determination of phospholipids hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Med 7:209–217CrossRefPubMed
19.
go back to reference Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic renal disease. Kidney Int 65:1009–1016CrossRefPubMed Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic renal disease. Kidney Int 65:1009–1016CrossRefPubMed
20.
go back to reference Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo L, Olmeda F, Caruso F, Tomasi A, Albertazzi A (2005) Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Artif Organs 29: 67–72CrossRefPubMed Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo L, Olmeda F, Caruso F, Tomasi A, Albertazzi A (2005) Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Artif Organs 29: 67–72CrossRefPubMed
21.
go back to reference Zwolinska D, Grzeszczak W, Kilis-Pstrusinska K, Szprynger K, Szczepanska M (2004) Lipid peroxidation and antioxidant enzymes in children with chronic renal failure. Pediatr Nephrol 19: 888–892PubMed Zwolinska D, Grzeszczak W, Kilis-Pstrusinska K, Szprynger K, Szczepanska M (2004) Lipid peroxidation and antioxidant enzymes in children with chronic renal failure. Pediatr Nephrol 19: 888–892PubMed
22.
go back to reference Sommerburg O, Grune T, Ehrich JH, Siems WG (2002) Adaptation of glutathione-peroxidase activity to oxidative stress occurs in children but not in adult patients with end-stage renal failure undergoing hemodialysis. Clin Nephrol 58 [Suppl 1]:S31–S36 Sommerburg O, Grune T, Ehrich JH, Siems WG (2002) Adaptation of glutathione-peroxidase activity to oxidative stress occurs in children but not in adult patients with end-stage renal failure undergoing hemodialysis. Clin Nephrol 58 [Suppl 1]:S31–S36
23.
go back to reference Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648–658CrossRefPubMed Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648–658CrossRefPubMed
24.
go back to reference Durak I, Kacmaz M, Elgun S, Ozturk HS (2004) Oxidative stress in patients with chronic renal failure: effects of hemodialysis. Med Princ Pract 13:84–87CrossRefPubMed Durak I, Kacmaz M, Elgun S, Ozturk HS (2004) Oxidative stress in patients with chronic renal failure: effects of hemodialysis. Med Princ Pract 13:84–87CrossRefPubMed
25.
go back to reference Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M (2005) IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—the good, the bad, and the ugly. Kidney Int 67:1226–1233 Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M (2005) IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—the good, the bad, and the ugly. Kidney Int 67:1226–1233
26.
go back to reference Noh H, Lee SW, Kang SW, Shin SK, Chol KH, Lee HY, Han DS (1998) Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 18:387–394PubMed Noh H, Lee SW, Kang SW, Shin SK, Chol KH, Lee HY, Han DS (1998) Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 18:387–394PubMed
27.
go back to reference Panichi V, Migliori M, DePietro S, Taccola D, Bianchi AM, Giovannini L, Norpoth M, Metelli MR, Cristofani R, Bertelli A, Sbragia G, Tetta C, Palla R (2002) C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron 91:594–600CrossRefPubMed Panichi V, Migliori M, DePietro S, Taccola D, Bianchi AM, Giovannini L, Norpoth M, Metelli MR, Cristofani R, Bertelli A, Sbragia G, Tetta C, Palla R (2002) C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron 91:594–600CrossRefPubMed
28.
go back to reference Himmelfarb J, McMonagle E (2001) Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60:358–363CrossRefPubMed Himmelfarb J, McMonagle E (2001) Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60:358–363CrossRefPubMed
29.
go back to reference Mackness B, Durrington P, McElduff P, Yarnell J, Azam N, Watt M, Mackness M (2003) Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 107:2775–2779CrossRefPubMed Mackness B, Durrington P, McElduff P, Yarnell J, Azam N, Watt M, Mackness M (2003) Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 107:2775–2779CrossRefPubMed
30.
go back to reference Gordon CA, Himmelfarb J (2004) Antioxidant therapy in uremia: evidence-based medicine? Semin Dial 17:327–332CrossRefPubMed Gordon CA, Himmelfarb J (2004) Antioxidant therapy in uremia: evidence-based medicine? Semin Dial 17:327–332CrossRefPubMed
Metadata
Title
Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure
Authors
Aydın Ece
Yıldız Atamer
Fuat Gürkan
Mehmet Davutoğlu
Meki Bilici
Murat Tutanç
Ali Güneş
Publication date
01-02-2006
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 2/2006
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-005-2079-2

Other articles of this Issue 2/2006

Pediatric Nephrology 2/2006 Go to the issue